Degenerative Disc Disease Treatment Market - Forecast(2021 - 2026)

 Degenerative Disc Disease Treatment Market   Overview

Degenerative Disc Disease Treatment Market   size is forecast to reach $1.7billion by 2025, growing at a CAGR of 9% during the forecast period 2020-2025. Degenerative Disc Disease refers to symptoms of back or neck pain caused by wear and tear on a spinal disc. Increasing cause of low back pains & neck pain in adults and increasing geriatric population are the major factors driving the growth of the market. Increase in sports and daily activities further enhance the overall market demand of degenerative disc disease treatment. 

• Request Sample

Report Coverage

The report: “Degenerative Disc Disease Treatment Market Forecast (2019-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Degenerative Disc Disease Treatment Market. 

By Drugs: Ibuprofen, Naproxen and COX-2 inhibitors

By Treatment Type: Occupational Therapy, Physical Therapy, Special Exercises, Medications, Losing Weights and Surgery

By End Users: Hospitals, Clinics and Others

By Geography: North America, Europe, Asia Pacific and Rest of the World.

• Inquiry Before Buying

Key Takeaways

• Europe dominates the Degenerative Disc Disease Treatment Market   in 2019 owing to increasing suffering from lumbar degenerative spine diseases and lower back pain. The degenerative disc disease treatment   market scope for different regions will be provided in the final report.
• Increasing radicular pain and numbness is likely to aid in the market growth of degenerative disc disease treatment market.
• Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Degenerative Disc Disease Treatment Market   report.
• High cost associated with degenerative disc disease treatments such as artificial disc replacement and spinal fusion create hurdles for the Degenerative Disc Disease Treatment Market 

• Schedule a Call

Drug- Segment Analysis

The Ibuprofen segment held the largest share in the Degenerative Disc Disease Treatment Market   in 2019 and is estimated to grow at a CAGR of 6.3% during the forecast period 2020-2025. Ibuprofen is a medication in the nonsteroidal anti-inflammatory drug  class that is used for treating pain, fever and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. Naproxen  also known as Aleve  is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis and fever and  is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours. Naproxen sodium is available as both an immediate release and as an extended release tablet. The extended release formulations take longer to take effect than the immediate release formulations and therefore are less useful when immediate pain relief is desired. Extended release formulations are more useful for the treatment of chronic or long-lasting, conditions in which long-term pain relief is desirable.  

Treatment Type- Segment Analysis

Occupational Therapy segment held the largest share in the Degenerative Disc Disease Treatment Market   in 2019. Occupational therapy is for back pain and focuses on using proper body mechanics which include using larger joints in movement, conserving energy by balancing work and rest, and listening to pain signals to avoid overexertion. Specific movements make the muscles in neck and back stronger and more flexible. This supports the spine. In most cases, physical therapy and pain medication are enough for long term relief. 

We also publish more than 100 reports every month in "Lifesciences and Healthcare”, Go through the Domain if there are any other areas for which you would like to get a market research study."